Literature DB >> 29018846

Antibiotics and specialized metabolites from the human microbiota.

Walaa K Mousa1, Bilal Athar, Nishanth J Merwin, Nathan A Magarvey.   

Abstract

Covering: 2000 to 2017Decades of research on human microbiota have revealed much of their taxonomic diversity and established their direct link to health and disease. However, the breadth of bioactive natural products secreted by our microbial partners remains unknown. Of particular interest are antibiotics produced by our microbiota to ward off invasive pathogens. Members of the human microbiota exclusively produce evolved small molecules with selective antimicrobial activity against human pathogens. Herein, we expand upon the current knowledge concerning antibiotics derived from human microbiota and their distribution across body sites. We analyze, using our in-house chem-bioinformatic tools and natural products database, the encoded antibiotic potential of the human microbiome. This compilation of information may create a foundation for the continued exploration of this intriguing resource of chemical diversity and expose challenges and future perspectives to accelerate the discovery rate of small molecules from the human microbiota.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29018846     DOI: 10.1039/c7np00021a

Source DB:  PubMed          Journal:  Nat Prod Rep        ISSN: 0265-0568            Impact factor:   13.423


  21 in total

Review 1.  Signaling Natural Products from Human Pathogenic Bacteria.

Authors:  Zhijuan Hu; Wenjun Zhang
Journal:  ACS Infect Dis       Date:  2019-10-30       Impact factor: 5.084

Review 2.  Emerging evolutionary paradigms in antibiotic discovery.

Authors:  Marc G Chevrette; Cameron R Currie
Journal:  J Ind Microbiol Biotechnol       Date:  2018-09-29       Impact factor: 3.346

3.  Biosynthetic Cyclization Catalysts for the Assembly of Peptide and Polyketide Natural Products.

Authors:  Maria L Adrover-Castellano; Jennifer J Schmidt; David H Sherman
Journal:  ChemCatChem       Date:  2021-01-28       Impact factor: 5.686

4.  Purification, Characterization, Mode of Action, and Application of Jileicin, a Novel Antimicrobial from Paenibacillus jilinensis YPG26.

Authors:  Ke Ma; Wei Chen; Shi-Qing Yan; Zhen-Zhen Liu; Xiao-Qi Lin; Jia-Bao Zhang; Yu Gao; Tao Wang; Jian-Gang Zhang; Yong-Jun Yang
Journal:  J Agric Food Chem       Date:  2022-05-02       Impact factor: 5.895

Review 5.  Accessing Bioactive Natural Products from the Human Microbiome.

Authors:  Aleksandr Milshteyn; Dominic A Colosimo; Sean F Brady
Journal:  Cell Host Microbe       Date:  2018-06-13       Impact factor: 21.023

6.  Acetate Activates Lactobacillus Bacteriocin Synthesis by Controlling Quorum Sensing.

Authors:  Fanqiang Meng; Haizhen Zhao; Ting Nie; Fengxia Lu; Chong Zhang; Yingjian Lu; Zhaoxin Lu
Journal:  Appl Environ Microbiol       Date:  2021-06-11       Impact factor: 4.792

7.  FengLiao affects gut microbiota and the expression levels of Na+/H+ exchangers, aquaporins and acute phase proteins in mice with castor oil-induced diarrhea.

Authors:  Wenlu Chen; Xinyu Peng; Jingxian Yu; Xuanxuan Chen; Minggui Yuan; Rong Xiang; Limei He; Danni Yu; Huahua Kang; Yufang Pan; Zhihong Xu
Journal:  PLoS One       Date:  2020-07-28       Impact factor: 3.240

Review 8.  Small molecule natural products in human nasal/oral microbiota.

Authors:  Colin Charles Barber; Wenjun Zhang
Journal:  J Ind Microbiol Biotechnol       Date:  2021-06-04       Impact factor: 3.346

Review 9.  Activation of microbial secondary metabolic pathways: Avenues and challenges.

Authors:  Bikash Baral; Amir Akhgari; Mikko Metsä-Ketelä
Journal:  Synth Syst Biotechnol       Date:  2018-09-12

Review 10.  Gut microbiota as a source of novel antimicrobials.

Authors:  Enriqueta Garcia-Gutierrez; Melinda J Mayer; Paul D Cotter; Arjan Narbad
Journal:  Gut Microbes       Date:  2018-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.